Printer Friendly

Thymic protein A. (Raw Material Research).

Raw Material: Thymic protein A

Indication: Chronic fatigue and immune dysfunction syndrome (CFIDS)

Source: Journal of Nutritional and Environmental Medicine, December 2001:11:241-247

Research: Thymic protein in oral formulation was tested in 23 CFIDS patients.

Results: Sixteen of 23 patients in the study showed marked improvement in immune system function, with a corresponding improvement of the clinical symptoms of CFIDS. Many patients reported dramatic improvements in the symptoms associated with CFIDS: These improvements included 47% in sleep quality, 43% reduction of food sensitivities, 53% reduction of chemical sensitivities, 47% improvement in short term memory, 79% improvement in depression, 100% improvement in panic reactions, as well as similar improvements in sore throat frequency, swollen lymph glands, nasal allergies, muscle weakness, anxiety and canker sores.
COPYRIGHT 2002 Rodman Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Nutraceuticals World
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 1, 2002
Previous Article:Vitamin E. (Raw Material Research).
Next Article:Dry Creek Nutrition: unlocking the secret to the French Paradox. (Supply Source).

Related Articles
Calcium citrate malate and protein intake. (Raw Material Research).
Immunity: examining nutraceuticals that can boost or modulate the body's defenses.
BioZate 1[R]. (Raw Material Research).
Knowledge of food physics will help innovative product creation.
Minimize variations in product quality.
Drinde helps manufacturers cut costs.
Protein and vitamins and enzymes, oh sprouts! Chockfull of a variety of nutrients in a concentrated package, sprouts offer a plethora of health...
Aberrant thymus and parathyroid gland presenting as a recurrent lateral neck mass: a case report.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters